Cart
sales@molnova.com
GSK2334470
CAS No. 1227911-45-6
GSK2334470( GSK2334470 | GSK 2334470 | GSK-2334470 )
Catalog No. M10881 CAS No. 1227911-45-6
GSK2334470 is a novel PDK1 inhibitor with IC50 of ~10 nM in a cell-free assay.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 43 | Get Quote |
|
| 10MG | 71 | Get Quote |
|
| 25MG | 133 | Get Quote |
|
| 50MG | 244 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGSK2334470
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK2334470 is a novel PDK1 inhibitor with IC50 of ~10 nM in a cell-free assay.
-
DescriptionGSK2334470 is a novel PDK1 inhibitor with IC50 of ~10 nM in a cell-free assay, with no activity at other close related AGC-kinases.
-
In Vitro——
-
In Vivo——
-
SynonymsGSK2334470 | GSK 2334470 | GSK-2334470
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPDK
-
RecptorPDK1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1227911-45-6
-
Formula Weight462.59
-
Molecular FormulaC25H34N8O
-
Purity>98% (HPLC)
-
SolubilityEthanol: 90 mg/mL (194.55 mM); DMSO: 90 mg/mL (194.55 mM)
-
SMILESO=C([C@@H]1CN(C2=NC(NC)=NC(C3=CC4=C(C=C3)C(N)=NN4)=C2)[C@H](C)CC1)NC5CCCCC5
-
Chemical Name(3S,6R)-1-(6-(3-amino-1H-indazol-6-yl)-2-(methylamino)pyrimidin-4-yl)-N-cyclohexyl-6-methylpiperidine-3-carboxamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Najafov A, et al. Biochem J, 2011, 433(2), 357-369.
molnova catalog
related products
-
OSU-03013
OSU-03013 (OSU 03013, OSU03013) is a novel potent, orally active 3-phosphoinositide-dependent kinase-1 (PDK-1) with IC50 of 2 uM.
-
RS1-PDK1 inhibitor
RS1-PDK1 inhibitor (RS 1) is a selective inhibitor of the protein kinase PDK1 that can be used to treat and prevent disease or disorders.
-
M77976
M77976 is a selective ATP-competitive inhibitor of pyruvate dehydrogenase kinase 4 (PDK4) with an inhibitory effect on PDK4, having an IC50 value of 648 μM. It is used for research related to obesity and diabetes.
